Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Sciatica is a term which is used to describe the symptoms such as leg pain, tingling, numbness, or weakness observed in lower back and travel through sciatic nerve in the back of the leg in individuals. Sciatica most commonly occurs in patients suffering from herniated disk, bone spur on the spine or narrowing of the spine (spinal stenosis), which leads to inflammation, pain, and numbness in the affected leg. Nonsurgical and surgical options for sciatica treatment are available. Nonsurgical techniques are usually attempted initially but when the underlying cause is severe and/or progressive neurological impairments, such as limb weakness, emerge, surgery may be recommended. First line treatments of sciatica typically include some combination of physical therapy, medications, chiropractic therapy, massage therapy, therapeutic injections (epidural steroid injections, selective nerve root blocks injection), and alternative therapies.

The global sciatica market is estimated to be valued at US$ 6,302.9 million in 2021 and is expected to increase to US$ 8,776.2 Mn by 2028, witnessing a CAGR of 4.8% over the forecast period (2021-2028).

Figure 1. Global Sciatica Market Share (%), By Region, 2021

Sciatica  | Coherent Market Insights

Robust product pipeline for the treatment of sciatica which are estimated to launch over the forecast period is expected to drive the growth of the global sciatica market.

The key players operating in the global sciatica market are focusing on vigorous product pipeline for the treatment of sciatica which are estimated to launch over the forecast period, is expected to drive the growth of the global sciatica market. For instance, on September 4, 2019, SpineThera Australia Pty Ltd, a wholly owned subsidiary of SpineThera, Inc., initiated a phase I/II clinical trial study to assess the safety and efficacy of two doses of SX600 administered by lumbosacral transforaminal epidural injection in patients with radicular pain secondary to lumbar intervertebral disc herniation. The study is estimated to complete by September 2022.

request-sample

Sciatica Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 6,302.9 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 4.8% 2028 Value Projection: US$ 8,776.2 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Disease Type: Acute Sciatica, Chronic Sciatica, Others
  • By Drug Class: Nonsteroidal Anti-Inflammatory Drugs, Oral Steroids, Anticonvulsant Agents, Tricyclic Antidepressants, Opioid Analgesics, Others
  • By Route of Administration: Oral, Injectable
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Companies covered:

Sorrento Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Amneal Pharmaceuticals LLC, Jubilant Life Sciences Ltd., Hikma Pharmaceuticals PLC., Mylan N.V., Horizon Therapeutics Plc., Sun Pharmaceutical Industries Ltd., Alkem Labs, SCILEX Pharmaceuticals, Inc., Seikagaku Corporation, Kolon Life Science, Inc., Teijin Limited, and SpineThera, Inc

Growth Drivers:
  • Increasing incidence and prevalence of sciatica
  • Robust product pipeline
Restraints & Challenges:
  • Potential side effects of drugs used in the treatment of sciatica

Figure 2. Global Sciatica Market Share (%), by Disease Type, 2021

Sciatica  | Coherent Market Insights

Global Sciatica Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe. The Coronavirus (COVID 19) pandemic and lockdown in various countries across the globe have impacted the financial status of businesses in all sectors. Private healthcare sector is one of the sector, which is majorly impacted by the COVID-19 pandemic. The COVID-19 pandemic caused major disruptions to clinical trial executions in the U.S., impacting key stakeholders across the industry. Investigative site capabilities experienced disturbances, driven by staff furloughs, social-distancing protocols, financial losses, and concerns over patient safety. Sponsors, contract research organizations, and other organizations that support drug development shifted to remote working environments. Recently, the U.S. Food and Drug Administration (FDA) guidance (March 2020 and updated on July 2020) acknowledged that the impact of COVID-19 may require companies conducting clinical trials to consider virtual patient visits or include novel ways for conducting clinical trials in place of current protocols. Therefore, there are now more opportunities for using remote healthcare including conducting virtual or decentralized trials, site-less clinical trials, and use of other non-traditional approaches that do not involve in-person visits.

Global Sciatica Market: Restraint

Potential side effects of drugs used in the treatment of sciatica and low patient compliance to the drugs such as anti-depressants and anticonvulsants due to its side effects is expected to restrain the market growth over the forecast period. Adverse events associated with epidural steroid injections include infection, bleeding, dural puncture nerve damage, cardiovascular system (heart) complications, risk associated with local anesthetics, and risk associated with steroids.

Key Players

Major players operating in the global sciatica market include Sorrento Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Amneal Pharmaceuticals LLC, Jubilant Life Sciences Ltd., Hikma Pharmaceuticals PLC., Mylan N.V., Horizon Therapeutics Plc., Sun Pharmaceutical Industries Ltd., Alkem Labs, SCILEX Pharmaceuticals, Inc., Seikagaku Corporation, Kolon Life Science, Inc., Teijin Limited, and SpineThera, Inc.

Sciatica refers to pain that radiates along the path of the sciatic nerve, which passes from lower back through hips to buttocks and down each leg. Typically, sciatica affects only one side of the body. This is often a chronic condition that is managed through the use of analgesics to control the pain and non-steroidal anti-inflammatory drugs (NSAIDS) to decrease inflammation. Sciatica is differentiated depending upon the severity of the pain faced by individuals such as acute sciatica, chronic sciatica, and others.

Acute sciatic is known as recent onset of pain in sciatic nerve for duration of four to eight weeks and pain can be self-managed by individuals through pain medications. In chronic sciatica, symptoms include persistent sciatic nerve pain, which lasts over eight weeks in individuals. There are two other types of sciatica which include alternating sciatica and bilateral sciatica. Alternating sciatica is a condition in which the sciatic nerve pain affects in both the legs alternately and thus may lead to degenerative problems in the sacroiliac joint. Bilateral sciatica is a condition in which the sciatic nerve pain occurs in both the legs together, this type of sciatic is very rare and may occur due to degenerative changes in the vertebrae and/or the disc at several spinal levels.

Market Dynamics

Increasing prevalence of sciatica is anticipated to drive the growth of global sciatica market over the forecast period. For instance, according to the article published in the Spine Health in December 2019, sciatica is common condition with a lifetime incidence varying from 10% to 40% of the population in the U.S.

Key features of the study:

  • This report provides in-depth analysis of the global sciatica market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global sciatica market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
  • Key companies covered as a part of this study include Sorrento Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Amneal Pharmaceuticals LLC, Jubilant Life Sciences Ltd., Hikma Pharmaceuticals PLC., Mylan N.V., Horizon Therapeutics Plc., Sun Pharmaceutical Industries Ltd., Alkem Labs, SCILEX Pharmaceuticals, Inc., Seikagaku Corporation, Kolon Life Science, Inc., Teijin Limited, and SpineThera, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global sciatica market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sciatica market

Detailed Segmentation:

  • Global Sciatica Market, By Disease Type:
    • Acute Sciatica
    • Chronic Sciatica
    • Others
  • Global Sciatica Market, By Drug Class:
    • Nonsteroidal Anti-Inflammatory Drugs
    • Oral Steroids
    • Anticonvulsant Agents
    • Tricyclic Antidepressants
    • Opioid Analgesics
    • Others
  • Global Sciatica Market, By Route of Administration:
    • Oral
    • Injectable
  • Global Sciatica Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Sciatica Market, By Region:        
    • North America
      • By Disease Type
        • Acute Sciatica
        • Chronic Sciatica
        • Others
      • By Drug Class
        • Nonsteroidal Anti-Inflammatory Drugs
        • Oral Steroids
        • Anticonvulsant Agents
        • Tricyclic Antidepressants
        • Opioid Analgesics
        • Others
      • By Route of Administration
        • Oral
        • Injectable
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Disease Type
        • Acute Sciatica
        • Chronic Sciatica
        • Others
      • By Drug Class
        • Nonsteroidal Anti-Inflammatory Drugs
        • Oral Steroids
        • Anticonvulsant Agents
        • Tricyclic Antidepressants
        • Opioid Analgesics
        • Others
      • By Route of Administration
        • Oral
        • Injectable
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Disease Type
        • Acute Sciatica
        • Chronic Sciatica
        • Others
      • By Drug Class
        • Nonsteroidal Anti-Inflammatory Drugs
        • Oral Steroids
        • Anticonvulsant Agents
        • Tricyclic Antidepressants
        • Opioid Analgesics
        • Others
      • By Route of Administration
        • Oral
        • Injectable
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Disease Type
        • Acute Sciatica
        • Chronic Sciatica
        • Others
      • By Drug Class
        • Nonsteroidal Anti-Inflammatory Drugs
        • Oral Steroids
        • Anticonvulsant Agents
        • Tricyclic Antidepressants
        • Opioid Analgesics
        • Others
      • By Route of Administration
        • Oral
        • Injectable
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Disease Type
        • Acute Sciatica
        • Chronic Sciatica
        • Others
      • By Drug Class
        • Nonsteroidal Anti-Inflammatory Drugs
        • Oral Steroids
        • Anticonvulsant Agents
        • Tricyclic Antidepressants
        • Opioid Analgesics
        • Others
      • By Route of Administration
        • Oral
        • Injectable
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Disease Type
        • Acute Sciatica
        • Chronic Sciatica
        • Others
      • By Drug Class
        • Nonsteroidal Anti-Inflammatory Drugs
        • Oral Steroids
        • Anticonvulsant Agents
        • Tricyclic Antidepressants
        • Opioid Analgesics
        • Others
      • By Route of Administration
        • Oral
        • Injectable
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Region/Country
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Sorrento Therapeutics, Inc.
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd.
    • Aurobindo Pharma Ltd.
    • Zydus Cadila
    • Glenmark Pharmaceuticals Ltd.
    • Amneal Pharmaceuticals LLC
    • Jubilant Life Sciences Ltd.
    • Hikma Pharmaceuticals PLC.
    • Mylan N.V.
    • Horizon Therapeutics Plc.
    • Sun Pharmaceutical Industries Ltd.
    • Alkem Labs
    • SCILEX Pharmaceuticals, Inc.
    • Seikagaku Corporation
    • Kolon Life Science, Inc.
    • Teijin Limited
    • SpineThera, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Disease Type
      • Market Snapshot, By Drug Class
      • Market Snapshot, By Route of Administration
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
      • Market Opportunity Map
  3. Global Sciatica Market Insights
    • Drivers
    • Restraints
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Merger, Acquisition & Agreements
    • Pipeline Analysis
    • Regulatory Scenario
    • Reimbursement Scenario
    • Market Trends
    • Recent Product Launch/Approvals
    • Treatment Algorithm
    • PEST Analysis
    • Epidemiology Based Model for Sciatica
  4. Global Sciatica Market - Impact of Coronavirus (Covid-19) Pandemic
    • Economic Impact
    • Epidemiology
    • Impact on Drug Development and Clinical Trials
  5. Global Sciatica Market, By Disease Type, 2017 – 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Acute Sciatica
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Chronic Sciatica
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
  6. Global Sciatica Market, By Drug Class, 2017 – 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Nonsteroidal Anti-Inflammatory Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Oral Steroids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Anticonvulsant Agents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Tricyclic Antidepressants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Opioid Analgesics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
  7. Global Sciatica Market, By Route of Administration, 2017 – 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
  8. Global Sciatica Market, By Distribution Channel, 2017 – 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
  9. Global Sciatica Market, By Region, 2017 – 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Route of Administration, 2017–2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2028, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017–2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2028, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Route of Administration, 2017–2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2028, (US$ Million)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Route of Administration, 2017–2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2028, (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Route of Administration, 2017–2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2028, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Route of Administration, 2017–2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Region/Country, 2017–2028, (US$ Million)
        • South Africa
        • Central Africa
        • North Africa
  10. Competitive Snapshot
    • Company Profiles
      • Sorrento Therapeutics, Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Aurobindo Pharma Ltd.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Zydus Cadila
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Glenmark Pharmaceuticals Ltd.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Amneal Pharmaceuticals LLC
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Jubilant Life Sciences Ltd.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Hikma Pharmaceuticals PLC
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Mylan N.V.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Horizon Therapeutics Plc
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Sun Pharmaceutical Industries Ltd.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Alkem Labs
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • SCILEX Pharmaceuticals, Inc
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Seikagaku Corporation
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Kolon Life Science, Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Teijin Limited
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • SpineThera, Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
  11. Section
    • Research Methodology
    • About us

*Browse 44 market data tables and 37 figures on "Sciatica Market” - Global forecast to 2028

FAQgrowicon

Frequently Asked Questions

The global sciatica market size is estimated to be valued at US$ 6,302.9 Million in 2021 and is expected to exhibit a CAGR of 4.8% between 2021 and 2028.
Increasing incidence and prevalence of sciatica and robust product pipeline are major driving factors for the market.
Nonsteroidal anti-inflammatory drugs is the major drug class segment in the market.
Potential side effects of drugs used in the treatment of sciatica is the major factor restraining growth of the market.
Major players operating in the market include Sorrento Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Amneal Pharmaceuticals LLC, Jubilant Life Sciences Ltd., Hikma Pharmaceuticals PLC., Mylan N.V., Horizon Therapeutics Plc., Sun Pharmaceutical Industries Ltd., Alkem Labs, SCILEX Pharmaceuticals, Inc., Seikagaku Corporation, Kolon Life Science, Inc., Teijin Limited, and SpineThera, Inc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.